Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,129.20
(
0.47%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
101.26
(
3.01%
)
Bitcoin
74,422.18
(
-0.56%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

ciotera

Send PM Follow Ignore
Followers 8
Posts 512
Boards Moderated 0
Alias Born 08/03/2005

ciotera

Re: DewDiligence post# 128809

Wednesday, 10/19/2011 2:41:19 PM

Wednesday, October 19, 2011 2:41:19 PM

Post# of 257253
RE: Musings on ABT’s split-up

Might be a good buying opportunity if the market overreacts and depresses the price of the proprietary pharma successor when it starts trading. Agree that Humira risk (as far as FOBs are concerned) is overblown and the pipeline looks very solid (relative to other big pharma).
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now